1,483
Views
10
CrossRef citations to date
0
Altmetric
Research Paper

ETS like-1 protein ELK1-induced lncRNA LINC01638 accelerates the progression of papillary thyroid cancer by regulating Axin2 through Wnt/β-catenin signaling pathway

&
Pages 3873-3885 | Received 29 Mar 2021, Accepted 21 May 2021, Published online: 19 Jul 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yunchao Xin, Xiaoling Shang, Xiaoran Sun, Guogang Xu, Yachao Liu & Yanbin Liu. (2022) SLC8A1 antisense RNA 1 suppresses papillary thyroid cancer malignant progression via the FUS RNA binding protein (FUS)/NUMB like endocytic adaptor protein (Numbl) axis. Bioengineered 13:5, pages 12572-12582.
Read now
Yelin Song, Jie Yu, LingLing Li, Lei Wang, Liangle Dong, Guangmin Xi, Yun Jing Lu & Zuowei Li. (2022) Luteolin impacts deoxyribonucleic acid repair by modulating the mitogen-activated protein kinase pathway in colorectal cancer. Bioengineered 13:4, pages 10998-11011.
Read now

Articles from other publishers (8)

Ruida Yang, Nan Yang, Pan Yin, Zihan Xue, Feidi Sun, Ruihan Fan, JiaFu Liang, Xinru Lv, Shaobo Wu & Liankang Sun. (2024) PCDH8 is a novel prognostic biomarker in thyroid cancer and promotes cell proliferation and viability. Functional & Integrative Genomics 24:2.
Crossref
Željana Matošić, Luka Šimunović, Tomislav Jukić, Roko Granić & Senka Meštrović. (2024) “Examining the link between tooth agenesis and papillary thyroid cancer: is there a risk factor?” Observational study. Progress in Orthodontics 25:1.
Crossref
Cristina Tous, Carmen Muñoz-Redondo, Angela Gavilán, Nereida Bravo-Gil, Fátima Baco-Antón, Elena Navarro-González, Guillermo Antiñolo & Salud Borrego. (2024) Delving into the Role of lncRNAs in Papillary Thyroid Cancer: Upregulation of LINC00887 Promotes Cell Proliferation, Growth and Invasion. International Journal of Molecular Sciences 25:3, pages 1587.
Crossref
姣 何. (2024) Advances in the Role and Regulatory Mechanisms of ELK1 in Malignant Tumors. Advances in Clinical Medicine 14:02, pages 3391-3397.
Crossref
Jonathan A. R. Gordon, Coralee E. Tye, Bodhisattwa Banerjee, Prachi N. Ghule, Andre J. van Wijnen, Fleur S. Kabala, Natalie A. Page, Michelle M. Falcone, Janet L. Stein, Gary S. Stein & Jane B. Lian. (2023) LINC01638 sustains human mesenchymal stem cell self-renewal and competency for osteogenic cell fate. Scientific Reports 13:1.
Crossref
Bo Chen, Deqing Liu, Runjie Chen, Libing Guo & Jianmin Ran. (2022) Elevated LINC00894 relieves the oncogenic properties of thyroid cancer cell by sponging let-7e-5p to promote TIA-1 expression. Discover Oncology 13:1.
Crossref
Jiansong Wang, Jianjun Luo, Xuecheng Wu & Zhuo Li. (2022) ELK1 suppresses SYTL1 expression by recruiting HDAC2 in bladder cancer progression. Human Cell 35:6, pages 1961-1975.
Crossref
Anqi Jin, Jin Zhou, Pengcheng Yu, Shichong Zhou & Cai Chang. (2022) High Expression of THBS1 Leads to a Poor Prognosis in Papillary Thyroid Cancer and Suppresses the Anti-Tumor Immune Microenvironment . Technology in Cancer Research & Treatment 21, pages 153303382210853.
Crossref